South Korea’s economic strength and supportive clinical trial infrastructure make it a robust setting to conduct your studies and pursue market entry. Quintiles’ in-market teams, backed by our global expertise, can help you initiate and sustain a successful local drug development program. Whether South Korea is your sole market of interest or simply part of a larger Asia Pacific strategy, trust Quintiles to increase your development and market access plans’ chance of success.